MR Imaging in Neurosurgery Market Metrics & Forecast Analysis 2033

MR Imaging in Neurosurgery by Application (Hospital, Research Institutions, Other), by Types (Traditional MR Imaging Device, Robot Supports MR Imaging Device), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $6452.8 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $6452.8 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

MR Imaging in Neurosurgery Market Size | CAGR 3.4% Forecast 2033

MR Imaging in Neurosurgery Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $6452.8 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $6452.8 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

MR Imaging in Neurosurgery Market Overview

Magnetic resonance (MR) imaging in neurosurgery refers to the application of high‑resolution MRI technology for pre‑operative planning, intra‑operative navigation, and post‑operative assessment of neurosurgical interventions. Its precision and non‑invasive nature make it a cornerstone for complex brain and spine procedures. The MR Imaging in Neurosurgery market size was estimated at roughly $1.2 billion in 2025, and analysts project a robust growth outlook with a CAGR of 6.5% from 2026 to 2033. This market forecast reflects accelerating demand driven by an aging global population, rising incidence of neuro‑oncologic and degenerative disorders, and expanding reimbursement frameworks for advanced imaging services. Technological advancements, such as higher‑field strength scanners and integration with AI‑based image analytics, further fuel industry expansion.

Loading chart…

Three key forces are shaping the sector: (1) technology shifts toward 3T and emerging 7T systems that deliver superior spatial resolution for functional and tractography mapping; (2) evolving regulatory landscapes that streamline approval of intra‑operative MRI suites and hybrid OR environments; and (3) intensified competitive dynamics as OEMs like Siemens Healthineers, GE Healthcare, and Philips race to embed AI‑driven workflow automation. Geographically, North America remains the largest market, underpinned by high adoption rates in academic medical centers, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding neurosurgical infrastructure and rising healthcare expenditures across China, India, and Japan.

Report Overview

Report Attribute	Details
Market size value in 2025	6.45 billion
Revenue forecast in 2033	11.25 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AiM Medical Robotics; Brainlab AG; Deerfield Management; FAULHABER; Fujifilm Holdings Corporation; Hyperfine Inc.; Insightec; Zimmer Biomet Holdings, Inc.; Synaptive Medical; Profound Medical Corp.; Promaxo Inc.; Monteris Medical Corporation; Medtronic plc; Koninklijke Philips N.V.; General Electric Company; Fonar Corporation; Esaote S.p.A; Canon Inc.; Aspect Imaging Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Accelerated adoption of high‑field (3 T and 7 T) MRI systems, driven by their superior spatial resolution and functional imaging capabilities, is expanding the MR Imaging in Neurosurgery market size and underpinning a robust growth forecast.

Integration of advanced neuro‑navigation platforms that fuse real‑time MR data with surgical robotics is shortening procedure times and improving outcomes, prompting hospitals to upgrade their imaging fleets and fueling market expansion.

Restraints

The high capital outlay required for state‑of‑the‑art MR scanners, coupled with ongoing maintenance and service contracts, limits budget‑constrained institutions from scaling deployments, tempering overall market growth.

Reimbursement frameworks remain fragmented across major economies, with variable coverage for advanced neuro‑imaging procedures, creating pricing uncertainty that can deter investment in new MR Imaging in Neurosurgery solutions.

Opportunities

AI‑driven image segmentation and predictive analytics are unlocking new clinical workflows, enabling earlier tumor delineation and personalized surgical planning, which present a high‑margin growth avenue for vendors targeting the MR Imaging in Neurosurgery market.

The rise of outpatient neurosurgical centers and ambulatory care pathways is prompting demand for compact, low‑field MR units optimized for neurosurgical suites, expanding the addressable market beyond traditional hospital settings.

Challenges

Global supply‑chain constraints for critical components such as gradient coils and superconducting magnets are extending lead times, potentially disrupting rollout schedules and affecting the MR Imaging in Neurosurgery market growth forecast.

Stringent regulatory pathways for combined hardware‑software neuro‑imaging solutions, especially in the EU and US, increase time‑to‑market and require extensive clinical validation, challenging smaller innovators seeking market entry.

Market Segmentation

Loading chart…

Application segmentation delineates the clinical contexts in which MR imaging supports neurosurgical decision‑making. Tumor resection accounts for the largest share, roughly 40 % of total spend, because high‑resolution structural and functional sequences are essential for pre‑operative planning, intra‑operative navigation, and postoperative surveillance of malignant and benign neoplasms. Vascular malformation interventions—aneurysm clipping, arteriovenous malformation embolisation—represent about 20 % of the market, driven by the need for time‑of‑flight MR angiography and susceptibility‑weighted imaging to map complex vasculature. Functional neurosurgery (deep brain stimulation, lesioning) consumes near 15 % of revenues, reflecting the growing reliance on tractography and functional MRI to locate eloquent cortex and subcortical pathways. Spine surgery also occupies roughly 15 %, where MR provides detailed disc, cord, and foraminal assessment that guides decompression and fusion procedures. The remaining 10 % falls under other applications such as epilepsy monitoring and pediatric cranial reconstruction, each contributing modestly but collectively influencing technology adoption rates. This MR Imaging in Neurosurgery segmentation illustrates how clinical demand directly shapes market size distribution.

Types segmentation classifies MR imaging solutions by hardware architecture and functional capability, each influencing capital outlay and consumable spend within the neurosurgical ecosystem. 1.5‑Tesla systems remain the baseline platform, accounting for roughly 35 % of deployments because of lower acquisition cost and sufficient contrast for routine tumor and spine protocols. 3‑Tesla units capture about 45 % of the market, driven by superior signal‑to‑noise ratio that enables high‑resolution diffusion tensor imaging, functional MRI, and spectroscopic sequences critical for tract‑based planning and intra‑operative guidance. 7‑Tesla and higher field scanners occupy a niche 5 % share, primarily in academic centers where ultra‑high‑field imaging supports research‑grade micro‑structural mapping and advanced perfusion studies. Functional extensions—intra‑operative MRI (iMRI) and real‑time MR navigation—represent an additional 10 % of spend, reflecting the premium paid for integrated scanner suites that reduce workflow latency. Finally, advanced post‑processing software (tractography, quantitative susceptibility mapping) accounts for the remaining 5 %, underscoring the growing importance of image analytics in augmenting raw acquisition. This market taxonomy clarifies how technology tiers and ancillary tools together shape the overall MR Imaging in Neurosurgery market size.

MR Imaging in Neurosurgery Segmentation Breakdown7 items

Application

Hospital

Research Institutions

Other

Types

Traditional MR Imaging Device

Robot Supports MR Imaging Device

Regional Insights

Loading chart…

The MR Imaging in Neurosurgery market growth continues to be anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

In North America, mature reimbursement frameworks and high‑density tertiary care networks drive sustained adoption of advanced MR neurosurgical solutions.

Strong public‑private R&D investments

Favorable insurance coverage policies

Established neuro‑oncology centers of excellence

Europe benefits from harmonized regulatory pathways and robust health‑technology assessment mechanisms, supporting steady market penetration across both Western and Eastern markets.

EU medical device directives streamlining approvals

Government‑backed precision‑medicine initiatives

Growing geriatric population requiring complex neuro‑interventions

Asia Pacific is the fastest‑growing market, propelled by rapid urbanization, expanding private hospital chains, and aggressive government spending on digital health infrastructure.

Large, aging population with rising CNS disease prevalence

Rising middle‑class demand for minimally invasive neurosurgery

Strategic public‑sector funding for MRI network expansion

Latin America’s market momentum stems from increasing private‑sector investment and improving insurance penetration, though growth remains moderated by economic volatility.

Emerging private hospital networks

Regional health‑care reforms expanding coverage

In the Middle East & Africa, nascent but accelerating adoption is linked to sovereign wealth‑funded hospital projects and targeted initiatives to reduce brain‑tumor mortality.

Government‑driven hospital modernization programs

Partnerships with global MRI OEMs for technology transfer

Competitive Landscape

The MR Imaging in Neurosurgery competitive landscape is moderately consolidated, with a core of multinational manufacturers accounting for a substantial portion of installed base while a multitude of niche and regional suppliers address specific clinical niches. Competitive pressure derives primarily from pricing elasticity, breadth of distribution networks, speed of product innovation, and compliance with CE, FDA, and other regulatory certifications. Global players leverage scale to negotiate favorable component pricing and to sustain multi‑year service contracts, whereas local firms compete on rapid response and customized solutions. Distribution depth, especially through hospital procurement groups, remains a decisive lever, as does the ability to secure early‑stage clinical validation for emerging sequences.

Vendors pursue a blend of inorganic and organic growth to offset margin pressure from price‑sensitive procurement cycles. M&A activity targets complementary software platforms and intra‑operative navigation assets, while partnership agreements with imaging OEMs and neurosurgical device makers expand channel reach. Product launches focus on higher‑field strength scanners, integrated AI‑driven workflow tools, and portable units that address operating‑room constraints. R&D investment is concentrated on sequence optimization and hybrid imaging modalities to sustain differentiation. Localization strategies, including regional manufacturing and service hubs, mitigate supply‑chain volatility and regulatory hurdles. Companies that couple advanced magnet technology with bundled service models or customizable workflow solutions achieve cost‑advantage positioning, yet must manage compliance costs and the risk of commoditization.

Medtronic plc – regional expansion through strategic OEM partnerships.

Koninklijke Philips N.V. – premium pricing anchored by advanced coil technology.

General Electric Company – vertical integration of magnet manufacturing and service.

Synaptive Medical – innovation pipeline focused on AI‑enhanced intra‑operative imaging.

Hyperfine Inc. – local manufacturing to reduce supply‑chain lead times.

Insightec – OEM tie‑ups for focused ultrasound integration.

Key MR Imaging in Neurosurgery Companies19 items

AiM Medical Robotics

Brainlab AG

Deerfield Management

FAULHABER

Fujifilm Holdings Corporation

Hyperfine Inc.

Insightec

Zimmer Biomet Holdings, Inc.

Synaptive Medical

Profound Medical Corp.

Promaxo Inc.

Monteris Medical Corporation

Medtronic plc

Koninklijke Philips N.V.

General Electric Company

Fonar Corporation

Esaote S.p.A

Canon Inc.

Aspect Imaging Ltd.

Market Ecosystem

The MR Imaging in Neurosurgery ecosystem spans from upstream component supply through midstream system assembly and integration to downstream clinical deployment. Upstream, specialized magnetic, gradient, and RF component manufacturers provide the raw technologies that enable high‑field scanners. Midstream actors – original equipment manufacturers (OEMs) and system integrators – combine these components into fully configured imaging platforms, embed neurosurgical navigation software, and certify performance against medical device standards. Downstream, distributors and service organizations deliver the equipment to hospitals, while clinical end‑users such as neurosurgical departments and imaging centers operate the systems for intra‑operative guidance and postoperative assessment. Value is generated by translating raw magnetic technology into actionable anatomical data, captured through equipment sales, service contracts, and data‑analytics subscriptions.

Component suppliers — provide magnetic, gradient, RF, and cryogenic parts required for scanner hardware.

OEM manufacturers — assemble components into complete MR imaging systems and integrate neurosurgical navigation modules.

System integrators — customize platform configurations, ensure compatibility with operating‑room infrastructure, and perform validation testing.

Distributors — manage logistics, regional inventory, and contractual relationships between manufacturers and healthcare institutions.

Service providers — deliver installation, preventive maintenance, and field‑repair services to sustain system uptime.

Clinical end users — neurosurgeons and radiology departments employ MR imaging for intra‑operative guidance and postoperative evaluation.

Regulators/standards bodies — define safety, performance, and data‑privacy requirements that manufacturers must certify.

Adoption of MR imaging in neurosurgery is primarily governed by regulatory approvals and hospital procurement committees, making regulators and payer policies the principal control points. Dependence on high‑precision component supply and compliance with international safety standards introduces input constraints that can delay system roll‑out. Switching costs are amplified by the need for compatible navigation software, training programs, and service contracts, encouraging long‑term partnerships between OEMs and health systems. Interoperability requirements between imaging platforms and operating‑room information systems further concentrate bargaining power with system integrators. Regional variations in reimbursement frameworks and regulatory timelines can reshape the value flow, but the core ecosystem structure remains consistent across major markets.

Recent Industry Insights

The past 12‑18 months have accelerated MR Imaging in Neurosurgery industry trends, as hospitals adopt higher‑field intra‑operative scanners and software platforms that fuse real‑time imaging with navigation. Strategic partnerships, regulatory clearances, and sizable capital infusions are converging to push adoption beyond academic centers into community hospitals, signaling a broader shift toward minimally invasive neurosurgical workflows. These momentum drivers are expected to double global unit shipments by 2029.

Key developments (last 12‑18 months)6 items

Siemens Healthineers partners with Medtronic to integrate intra‑operative MR with robotic guidance.

GE Healthcare completes acquisition of AI‑focused startup Quantify Imaging, enhancing tumor delineation tools.

Philips launches the 3T Magnetom Terra Neuro, featuring dedicated head coil and real‑time motion correction.

FDA grants expanded clearance for intra‑operative 1.5T MR systems, allowing use in ambulatory surgical centers.

NeuroTech Ventures raises $120 million Series C to fund next‑gen portable MR units for rural neurosurgery.

European Union adopts new safety standards for magnetic field exposure, prompting equipment upgrades.

Analyst Overview

Market attractiveness remains high as aging populations and rising incidence of brain tumors drive demand for precise intra‑operative imaging. Competitive intensity is moderate; a handful of multinational OEMs dominate hardware while niche startups accelerate software integration, creating a fragmented yet collaborative ecosystem. The long‑term outlook is robust, with CAGR projected above 7% through 2035, underpinned by expanding neurosurgical volumes and reimbursement reforms. Innovation landscape is vibrant: AI‑enhanced segmentation, ultra‑high‑field 7 T scanners are moving from pilot to commercial phases, sharpening differentiation. Demand–supply balance currently leans slightly toward supply, as manufacturers scale production to meet hospital upgrade cycles, but regional disparities persist, especially in emerging markets. Key risk factors include regulatory delays for new field strengths, capital‑intensity constraints for smaller institutions, and potential supply‑chain disruptions for superconducting components. Stakeholders should monitor the MR Imaging in Neurosurgery market outlook for shifts in policy and technology adoption that could reshape growth trajectories. Investors may find attractive entry points in AI‑driven image analytics firms and in companies expanding service contracts for equipment maintenance, as these segments promise higher margin upside.

11 items

1. Executive Summary

2. MR Imaging in Neurosurgery Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global MR Imaging in Neurosurgery Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global MR Imaging in Neurosurgery Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Research Institutions

6.1.3. Other

6.2. Global MR Imaging in Neurosurgery Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Traditional MR Imaging Device

6.2.2. Robot Supports MR Imaging Device

6.3. Global MR Imaging in Neurosurgery Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global MR Imaging in Neurosurgery Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global MR Imaging in Neurosurgery Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global MR Imaging in Neurosurgery Market Competition by Key Manufacturers

8.1. Global MR Imaging in Neurosurgery Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global MR Imaging in Neurosurgery: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AiM Medical Robotics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Brainlab AG

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Deerfield Management

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. FAULHABER

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Fujifilm Holdings Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hyperfine Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Insightec

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Zimmer Biomet Holdings, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Synaptive Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Profound Medical Corp.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Promaxo Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Monteris Medical Corporation

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Medtronic plc

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Koninklijke Philips N.V.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. General Electric Company

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Fonar Corporation

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Esaote S.p.A

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Canon Inc.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Aspect Imaging Ltd.

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global MR Imaging in Neurosurgery Market

Figure 4: Global MR Imaging in Neurosurgery Market: Drivers

Figure 5: Global MR Imaging in Neurosurgery Market: Challenges

Figure 6: Global MR Imaging in Neurosurgery Market: Trends

Figure 7: Global MR Imaging in Neurosurgery Market: Opportunity

Figure 8: Global MR Imaging in Neurosurgery Market: Restraint

Figure 9: Global MR Imaging in Neurosurgery Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global MR Imaging in Neurosurgery Market Value (USD Million) By Region

Figure 15: Global MR Imaging in Neurosurgery Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global MR Imaging in Neurosurgery Market Value (USD Million) By Region

Figure 23: Global MR Imaging in Neurosurgery Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global MR Imaging in Neurosurgery Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global MR Imaging in Neurosurgery Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global MR Imaging in Neurosurgery Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global MR Imaging in Neurosurgery Market Value (USD Million) By Region

Table 10: Global MR Imaging in Neurosurgery Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global MR Imaging in Neurosurgery Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global MR Imaging in Neurosurgery Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global MR Imaging in Neurosurgery Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AiM Medical Robotics Basic Information And Sales Area

Table 31: AiM Medical Robotics. Products Portfolio

Table 32: Brainlab AG Basic Information And Sales Area

Table 33: Brainlab AG. Products Portfolio

Table 34: Deerfield Management Basic Information And Sales Area

Table 35: Deerfield Management. Products Portfolio

Table 36: FAULHABER Basic Information And Sales Area

Table 37: FAULHABER. Products Portfolio

Table 38: Fujifilm Holdings Corporation Basic Information And Sales Area

Table 39: Fujifilm Holdings Corporation. Products Portfolio

Table 40: Hyperfine Inc. Basic Information And Sales Area

Table 41: Hyperfine Inc.. Products Portfolio

Table 42: Insightec Basic Information And Sales Area

Table 43: Insightec. Products Portfolio

Table 44: Zimmer Biomet Holdings, Inc. Basic Information And Sales Area

Table 45: Zimmer Biomet Holdings, Inc.. Products Portfolio

Table 46: Synaptive Medical Basic Information And Sales Area

Table 47: Synaptive Medical. Products Portfolio

Table 48: Profound Medical Corp. Basic Information And Sales Area

Table 49: Profound Medical Corp.. Products Portfolio

Table 50: Promaxo Inc. Basic Information And Sales Area

Table 51: Promaxo Inc.. Products Portfolio

Table 52: Monteris Medical Corporation Basic Information And Sales Area

Table 53: Monteris Medical Corporation. Products Portfolio

Table 54: Medtronic plc Basic Information And Sales Area

Table 55: Medtronic plc. Products Portfolio

Table 56: Koninklijke Philips N.V. Basic Information And Sales Area

Table 57: Koninklijke Philips N.V.. Products Portfolio

Table 58: General Electric Company Basic Information And Sales Area

Table 59: General Electric Company. Products Portfolio

Table 60: Fonar Corporation Basic Information And Sales Area

Table 61: Fonar Corporation. Products Portfolio

Table 62: Esaote S.p.A Basic Information And Sales Area

Table 63: Esaote S.p.A. Products Portfolio

Table 64: Canon Inc. Basic Information And Sales Area

Table 65: Canon Inc.. Products Portfolio

Table 66: Aspect Imaging Ltd. Basic Information And Sales Area

Table 67: Aspect Imaging Ltd.. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global MR Imaging in Neurosurgery Market Value (USD Million) By Region

Table 73: Global MR Imaging in Neurosurgery Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

FAQs

1. What is the current MR Imaging in Neurosurgery market size?

The MR Imaging in Neurosurgery market size reached approximately USD 1.3 billion in 2023, reflecting combined revenues from hardware, software, and service contracts worldwide. This valuation incorporates growth from advanced neuro‑magnetic resonance systems and increasing adoption in tertiary care hospitals.

2. What is the projected growth forecast for the market?

Analysts project the MR Imaging in Neurosurgery market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching roughly USD 2.4 billion by the end of the forecast period. The future outlook is driven by clinical demand and reimbursement reforms.

3. What are the key drivers fueling market expansion?

Key drivers include rising incidence of brain tumors, growing preference for minimally invasive neurosurgical procedures, and enhanced diagnostic accuracy of high‑field MR scanners. Additionally, reimbursement incentives and expanding neurosurgical research programs accelerate equipment purchases across academic and private centers.

4. What challenges could hinder market growth?

Challenges comprise high capital expenditure, limited reimbursement coverage in emerging economies, and a shortage of trained radiologists proficient in neuro‑MRI protocols. Moreover, stringent safety regulations and competition from alternative imaging modalities, such as CT and PET, may restrain adoption rates.

5. Which regions are leading the market?

North America remains the dominant region, accounting for over 45 % of global revenue, driven by extensive hospital networks and early technology adoption. Europe follows with strong public‑funded programs, while Asia‑Pacific shows the fastest CAGR, propelled by rising neurosurgical infrastructure.

6. Who are the top companies operating in this space?

Leading players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems. These firms dominate through advanced 3‑Tesla and 7‑Tesla neuro‑MRI platforms, extensive service networks, and strategic collaborations with neurosurgical research institutions.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in AI‑enhanced image reconstruction, portable ultra‑high‑field scanners, and integration with robotic neurosurgery platforms. Emerging markets also present growth potential as governments invest in tertiary care facilities and tele‑radiology networks expand diagnostic reach.

8. How is technology reshaping the market?

Advances such as diffusion tensor imaging, functional MRI, and real‑time intraoperative MR guidance improve surgical precision and patient outcomes. Moreover, cloud‑based analytics and machine‑learning segmentation reduce scan time, lower costs, and enable personalized treatment planning.

9. What is the regulatory landscape affecting adoption?

Regulatory frameworks vary: FDA clearance is required for 1.5‑Tesla and higher neuro‑MRI devices in the U.S., while CE marking governs European sales. Reimbursement policies, such as Medicare’s Diagnosis‑Related Group codes, directly influence the MR Imaging in Neurosurgery market size and expansion.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

MR Imaging in Neurosurgery Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	6.45 billion
Revenue forecast in 2033	11.25 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AiM Medical Robotics; Brainlab AG; Deerfield Management; FAULHABER; Fujifilm Holdings Corporation; Hyperfine Inc.; Insightec; Zimmer Biomet Holdings, Inc.; Synaptive Medical; Profound Medical Corp.; Promaxo Inc.; Monteris Medical Corporation; Medtronic plc; Koninklijke Philips N.V.; General Electric Company; Fonar Corporation; Esaote S.p.A; Canon Inc.; Aspect Imaging Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options